TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04642287

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study was withdrawn due to lack of financial support.”

The sponsor’s own words in the registry.

Life of this trial

20202021202220232024202520262027Registered2020-11-04Withdrawn (as of)2025-05-07Planned start2026-01 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Massachusetts General Hospital
Sponsor type
University, hospital or other
Conditions
Immunotherapy; Cutaneous Squamous Cell Carcinoma; Actinic Keratoses; Organ Transplant Recipients; Skin Cancer
Interventions
Calcipotriol Only Product in Cutaneous Dose Form; Vaseline; Topical 5FU
Participants
0
Sites
2
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.